Tadashi Kumamoto

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.

Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.

Journal: Pediatric blood & cancer

Published: April 30, 2024

Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Journal: International journal of hematology

Published: December 27, 2023

Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.

Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.

Journal: JCO precision oncology

Published: July 06, 2023

TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.

TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.

Journal: International journal of hematology

Published: April 26, 2023

Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single-institution retrospective analysis.

Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single-institution retrospective analysis.

Journal: Pediatric blood & cancer

Published: December 06, 2022

Correction to: Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.

Correction to: Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.

Journal: International journal of clinical oncology

Published: December 03, 2021

Surgical Treatment for Pneumothorax and Tumor-bronchial Fistula Secondary to Pulmonary Metastasis of Osteosarcoma in Pediatric and Adolescent Patients.

Surgical Treatment for Pneumothorax and Tumor-bronchial Fistula Secondary to Pulmonary Metastasis of Osteosarcoma in Pediatric and Adolescent Patients.

Journal: Journal of pediatric hematology/oncology

Published: August 18, 2021

Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.

Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.

Journal: Cancer chemotherapy and pharmacology

Published: July 18, 2021

Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.

Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.

Journal: Cancer science

Published: May 01, 2021

Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.

Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.

Journal: International journal of hematology

Published: April 21, 2021

Phase III study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients.

Phase III study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients.

Journal: Japanese journal of clinical oncology

Published: February 17, 2021

Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.

Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.

Journal: International journal of clinical oncology

Published: February 04, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026